Brainstorm Cell Therapeutics
Business Services · New York, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1325 Avenue of Americas Fl 28, New York ...Phone Number
(201) 488-0460Website
www.brainstorm-cell.comRevenue
-Stock Symbol
BCLIIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Brainstorm Cell Therapeutics
Brainstorm Cell Therapeutics is a biotechnology company focused on developing innovative stem cell therapies for neurodegenerative diseases. Founded in 2000, the company specializes in autologous adult stem cell therapeutics, particularly through its NurOwn technology platform that produces specialized cells for treating conditions like amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS). The company has conducted advanced clinical trials for these treatments, with its therapies receiving Orphan Drug designation from both US and European regulatory authorities. Brainstorm operates internationally with research and development facilities across multiple regions including North America, the Middle East, and Asia.Explore more
Brainstorm Cell Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Brainstorm Cell Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Brainstorm Cell Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Brainstorm Cell Therapeutics has new funding data
Check out if Brainstorm Cell Therapeutics is spiking on competitors!
Product Launch: Get notified when Brainstorm Cell Therapeutics launches new products
Earning: See what the market has to say on Brainstorm Cell Therapeutics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Brainstorm Cell Therapeutics
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Brainstorm Cell Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Click to see if Brainstorm Cell Therapeutics had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Brainstorm Cell Therapeutics
Find 2 more new buyers
Compare Similar Companies to Brainstorm Cell Therapeutics
Compare insights from companies similar to Brainstorm Cell Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Brainstorm Cell Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Brainstorm Cell Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Brainstorm Cell Therapeutics.
Brainstorm Cell Therapeutics financials insights
Gather financial insights about Brainstorm Cell Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2011
Private Equity
$250K
Private Equity
$3.6M
2012
Stock Offering
$5.7M
2014
Multiple Rounds
$16.6M
2017
Grant
$2.1M
Grant
$16M
2019
Grant
$496K
2020
Stock Offering
$10M
Debt
$150K
2026
Stock/Share Issuance
$1M
Brainstorm Cell Therapeutics Tech Stack
A closer look at the technologies used by Brainstorm Cell Therapeutics
See more technologies
Most Recent Scoops
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Funding
Funding
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Brainstorm Cell Therapeutics News & Media
BrainStorm Cell Therapeutics Appoints Former FDA Associate Commissioner Peter J. Pitts to Board of Directors
Former Senior FDA Official Joins Board as Company Prepares to Initiate Historic Phase 3b ALS Trial Under Special Protocol Assessment NEW YORK, May 28, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of autologous stem cell therapies for...BrainStorm Cell Therapeutics Announces Aggregate of $400,000 in Private Placements Priced at Premium to Market
$2.4 Million in H1 2026 Capital Raises Ahead of Phase 3b ENDURANCE Trial NEW YORK, May 19, 2026 /PRNewswire/ -- May 19, 2026 – BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapies for neurodegenerative diseases, today announced that in May it...BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides ...
/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...BrainStorm Cell Therapeutics Announces First Quarter 2026 Financial Results and Provides Corporate Update
NEW YORK, May 15, 2026 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (OTCQB: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today announced financial results for the three months ended March 31, 2026, and provided a corporate update. "The...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Brainstorm Cell Therapeutics
Sign Up For FreeTo access detailed company insights
Brainstorm Cell Therapeutics is a biotechnology company focused on developing innovative stem cell therapies for neurodegenerative diseases. Founded in 2000, the company specializes in autologous adult stem cell therapeutics, particularly through its NurOwn technology platform that produces specialized cells for treating conditions like amyotrophic... Read More
